Medication info

VL Injection (L-Carnitine)

Prescription medicationIntravenous injectionExpired
Ingredient · strength
L-Carnitine›200mg / 1mL
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
A clear colorless to light yellow liquid in a brown transparent ampoule
Packaging
5 ampoules/box [(10 milliliters/ampoule)]
Approval status
Expired

MFDS item code 201507669 · Notified 2015.11.11

This product's status changed to Expired on 2025.11.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of carnitine deficiency (including in dialysis patients) and ischemic myocardial metabolic disorders
Who receives it
Adults
Adult administration
1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2 ~ 3 grams per day of L-carnitine, divided into 2 ~ 3 doses, by intramuscular or intravenous injection. Adjust the dose appropriately according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10 ~ 20 milligrams / kilogram intravenously over 2 ~ 3 minutes at the end of each hemodialysis session. However, the dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of carnitine deficiency (including in dialysis patients) and ischemic myocardial metabolic disorders

  • Primary carnitine deficiency
  • secondary carnitine deficiency
  • myocardial metabolic disorders due to ischemic heart disease
  • angina pectoris
  • acute myocardial infarction
  • carnitine deficiency in patients with end-stage kidney disease
View approved original text

This medication is used to treat primary and secondary carnitine deficiency. It is also helpful in treating myocardial metabolic disorders caused by ischemic heart disease, such as angina pectoris and acute myocardial infarction. It is effective for carnitine deficiency occurring in patients with end-stage kidney disease undergoing hemodialysis. Overall, it is used to improve metabolic problems related to the heart and kidneys.

How it is given

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2 ~ 3 grams per day of L-carnitine, divided into 2 ~ 3 doses, by intramuscular or intravenous injection. Adjust the dose appropriately according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10 ~ 20 milligrams / kilogram intravenously over 2 ~ 3 minutes at the end of each hemodialysis session. However, the dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

Precautions

Care should be taken when opening the injection vial as there is a risk of glass pieces contaminating the solution. Special caution is needed when used by children or the elderly. This medication should not be used by persons who are allergic to it. Transient nausea or vomiting may occur after use. Rarely, body odor or gastritis may develop. There is a risk of seizures occurring more frequently or severely in patients with a history of seizures. Various side effects have also been reported in patients undergoing chronic hemodialysis, so caution is required. Side effects may include abdominal pain, headache, pain at the injection site, allergic reactions, cardiac rhythm abnormalities, blood pressure changes, indigestion, diarrhea, constipation, and others. Additionally, neurological symptoms such as muscle pain, dizziness, anxiety, depression, and insomnia may occur. Women who are pregnant or may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been established during pregnancy. Nursing mothers should use this medication cautiously as it may be passed into breast milk.

Side effects

  • temporary zones
  • vomiting
  • body odor
  • gastritis
  • seizures
  • abdominal pain
  • accidental injury
  • allergic reactions
  • asthma
  • back pain
Show 59 more
  • chest pain
  • fever
  • flu-like syndrome
  • headache
  • infection
  • injection site reactions
  • pain
  • arrhythmia
  • ventricular fibrillation
  • cardiovascular diseases
  • abnormal electrocardiogram
  • bleeding
  • hypertension
  • hypotension
  • palpitations
  • tachycardia
  • blood disorders
  • loss of appetite
  • constipation
  • diarrhea
  • dyspepsia
  • gastrointestinal disorders
  • bloody stools
  • gastrointestinal motility disorders
  • parathyroid disorders
  • anemia
  • hypercalcemia
  • hyperkalemia
  • hypervolemia
  • peripheral edema
  • weight loss
  • weight gain
  • leg cramps
  • myalgia
  • anxiety
  • depression
  • dizziness
  • drug dependence
  • tension
  • insomnia
  • sensory disturbances
  • vertigo
  • bronchitis
  • increased cough
  • shortness of breath
  • pharyngitis
  • respiratory diseases
  • rhinitis
  • sinusitis
  • pruritus
  • rash
  • amblyopia
  • eye diseases
  • taste disturbances
  • urinary tract infection
  • renal failure
  • hives
  • facial edema
  • myasthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. It is also recommended to store it at a temperature between 1 degree Celsius and 30 degrees Celsius, which is room temperature.

Appearance and packaging

Appearance

A clear colorless to light yellow liquid in a brown transparent ampoule

Package unit

5 ampoules/box [(10 milliliters/ampoule)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.